Rachel Sampson – Page 9 – Clinical Trial Results

Dr. M. Trejeeve Martyn and Dr. C. Michael Gibson discuss: The importance of early screening, diagnosis, and treatment for ATTR-CM

May 19, 2025

Disclosures: Sponsored by BridgeBio Pharma, Inc.

Dr. Adam Castano and Dr. C. Michael Gibson discuss: ACT-EARLY, a Phase 3 Study – Clinical Trial Results

May 12, 2025

Disclosures: Sponsored by BridgeBio Pharma, Inc

Dr. Sekar Kathiresan and Dr. C. Michael Gibson discuss “one and done” gene editing for high cholesterol by permanently inhibiting PCSK9 by about 70% to achieve an average LDL lowering of 59%.

April 14, 2025

Disclosures TBD

#ACC2025 Obesity Wrap Up:

April 14, 2025

Dr. Danielle Belardo and Dr. C. Michael Gibson discuss the PRAGUE-25 trial (catheter ablation vs. antiarrhythmics with weight management and […]

Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson discuss best practices for titration of GLP-1 medications for optimal weight loss.

February 17, 2025

Disclosures: TBD

Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson explore the question of what is the right weight reduction for each patient taking GLP-1 medications?

February 12, 2025

Disclosures: TBD

Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson discuss the SUMMIT trial and how GLP-1 agonists may be a new pillar in the treatment for HFpEF and obesity.

January 30, 2025

Disclosures: TBD

Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson discuss new oral semaglutide and the SOUL trial which lowered death, MI and stroke rates by 14% in patients with diabetes.

December 18, 2024

Disclosures: TBD

Dr. McGuire, Dr. Jastreboff and Dr. C Michael Gibson discuss the SURMOUNT 1 Trial of Tirzepatide and how we may be able to diminish the progression from pre-diabetes to diabetes.

December 9, 2024

Disclosures: TBD

von Willebrand factor molecules cross link and form a net around a blood clot holding it together. Drs. Shahid Nimjee and Gibson discuss a new vWf inhibitor that breaks apart this net & opening closed arteries but leaving a patch of fibrin strands across the site of plaque rupture which would have been dissolved by fibrinolytics potentially causing bleeding.

December 4, 2024

Disclosures: TBD